188 related articles for article (PubMed ID: 19876919)
1. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
2. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
4. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
Bright MD; Garner AP; Ridley AJ
Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
[TBL] [Abstract][Full Text] [Related]
5. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
[TBL] [Abstract][Full Text] [Related]
6. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
[TBL] [Abstract][Full Text] [Related]
7. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745
[TBL] [Abstract][Full Text] [Related]
8. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
9. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN
Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688
[TBL] [Abstract][Full Text] [Related]
10. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
[TBL] [Abstract][Full Text] [Related]
11. P21-activated protein kinase 1 induces colorectal cancer metastasis involving ERK activation and phosphorylation of FAK at Ser-910.
Li LH; Zheng MH; Luo Q; Ye Q; Feng B; Lu AG; Wang ML; Chen XH; Su LP; Liu BY
Int J Oncol; 2010 Oct; 37(4):951-62. PubMed ID: 20811717
[TBL] [Abstract][Full Text] [Related]
12. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.
Coniglio SJ; Zavarella S; Symons MH
Mol Cell Biol; 2008 Jun; 28(12):4162-72. PubMed ID: 18411304
[TBL] [Abstract][Full Text] [Related]
13. Expansion of BCR/ABL1
Edlinger L; Berger-Becvar A; Menzl I; Hoermann G; Greiner G; Grundschober E; Bago-Horvath Z; Al-Zoughbi W; Hoefler G; Brostjan C; Gille L; Moriggl R; Spittler A; Sexl V; Hoelbl-Kovacic A
Br J Haematol; 2017 Oct; 179(2):229-241. PubMed ID: 28707321
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
16. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
17. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
Song B; Wang W; Zheng Y; Yang J; Xu Z
J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
[TBL] [Abstract][Full Text] [Related]
18. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.
Prudnikova TY; Villamar-Cruz O; Rawat SJ; Cai KQ; Chernoff J
Oncogene; 2016 Apr; 35(17):2178-85. PubMed ID: 26257058
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
